Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center
Endokrynologia Polska · 2025
DOI: 10.5603/ep.109670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, 2025. Verfasst von Jolanta Krajewska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland. j…. Hauptthemen laut MEDLINE: Quinolines, Thyroid Neoplasms, Phenylurea Compounds, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland. jolanta.krajewska@io.gliwice.pl.
- Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
- Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
- Depertment of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
- Ist Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
ORCID-Profile: Jolanta Krajewska, Barbara Jarząb, Agata Wilk, Daria Handkiewicz-Junak
Zitieren
APA
Krajewska, J., Jarząb, B., Wilk, A., Kukulska, A., Krol, A., Drosik-Rutowicz, K., Kolton, M., & Handkiewicz-Junak, D. (2025). Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center. Endokrynologia Polska. https://doi.org/10.5603/ep.109670
Vancouver
Krajewska J, Jarząb B, Wilk A, Kukulska A, Krol A, Drosik-Rutowicz K, et al. Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center. Endokrynologia Polska. 2025. doi:10.5603/ep.109670
BibTeX
@article{Krajewska2025,
author = {Krajewska, Jolanta and Jarząb, Barbara and Wilk, Agata and Kukulska, Aleksandra and Krol, Aleksandra and Drosik-Rutowicz, Katarzyna and Kolton, Magdalena and Handkiewicz-Junak, Daria},
title = {Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center},
journal = {Endokrynologia Polska},
year = {2025},
doi = {10.5603/ep.109670}
}
EUVIMED